title: Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells.
abstract: Understanding the process of inducing T cell activation has been hampered by the complex interactions between APC and inflammatory Th1 cells. To dissociate Ag-specific signaling through the TCR from costimulatory signaling, rTCR ligands (RTL) containing the alpha1 and beta1 domains of HLA-DR2b (DRA*0101:DRB1*1501) covalently linked with either the myelin basic protein peptide 85-99 (RTL303) or CABL-b3a2 (RTL311) peptides were constructed to provide a minimal ligand for peptide-specific TCRs. When incubated with peptide-specific Th1 cell clones in the absence of APC or costimulatory molecules, only the cognate RTL induced partial activation through the TCR. This partial activation included rapid TCR zeta-chain phosphorylation, calcium mobilization, and reduced extracellular signal-related kinase activity, as well as IL-10 production, but not proliferation or other obvious phenotypic changes. On restimulation with APC/peptide, the RTL-pretreated Th1 clones had reduced proliferation and secreted less IFN-gamma; IL-10 production persisted. These findings reveal for the first time the rudimentary signaling pattern delivered by initial engagement of the external TCR interface, which is further supplemented by coactivation molecules. Activation with RTLs provides a novel strategy for generating autoantigen-specific bystander suppression useful for treatment of complex autoimmune diseases.
authors.affiliation: Department of Neurology, Oregon Health and Science University, Portland, OR 97201, USA. ggb@ohsu.edu
authors.forename: G G
authors.initials: GG
authors.lastname: Burrows
authors.forename: Y K
authors.initials: YK
authors.lastname: Chou
authors.forename: C
authors.initials: C
authors.lastname: Wang
authors.forename: J W
authors.initials: JW
authors.lastname: Chang
authors.forename: T P
authors.initials: TP
authors.lastname: Finn
authors.forename: N E
authors.initials: NE
authors.lastname: Culbertson
authors.forename: J
authors.initials: J
authors.lastname: Kim
authors.forename: D N
authors.initials: DN
authors.lastname: Bourdette
authors.forename: D A
authors.initials: DA
authors.lastname: Lewinsohn
authors.forename: D M
authors.initials: DM
authors.lastname: Lewinsohn
authors.forename: M
authors.initials: M
authors.lastname: Ikeda
authors.forename: T
authors.initials: T
authors.lastname: Yoshioka
authors.forename: C N
authors.initials: CN
authors.lastname: Allen
authors.forename: H
authors.initials: H
authors.lastname: Offner
authors.forename: A A
authors.initials: AA
authors.lastname: Vandenbark
mesh_terms: D020013:Calcium Signaling; D002999:Clone Cells; D016044:Fusion Proteins, bcr-abl / Q000276:immunology; D019674:Genes, T-Cell Receptor beta; D015802:HLA-DR2 Antigen / Q000235:genetics / Q000276:immunology*; D006801:Humans; D016753:Interleukin-10 / Q000378:metabolism*; D008024:Ligands; D009103:Multiple Sclerosis / Q000276:immunology; D004676:Myelin Basic Protein / Q000276:immunology; D010446:Peptide Fragments / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000378:metabolism*; D015398:Signal Transduction; D018417:Th1 Cells / Q000276:immunology*
chemical_list: D015802:HLA-DR2 Antigen; D008024:Ligands; D004676:Myelin Basic Protein; D010446:Peptide Fragments; D011948:Receptors, Antigen, T-Cell; C107908:myelin basic protein 85-99; D016753:Interleukin-10; D016044:Fusion Proteins, bcr-abl